About this medicine
- Approved name
- Lorazepam Macure 4 mg/ml, solution for injection
- International non-proprietary name (INN) or common name
- lorazepam
About this procedure
- Current status
- European Commission final decision
- Reference number
- EMEA/H/A-13/1536
- Type
- Article 13 referrals
This type of referral is triggered for a medicine that has been authorised by mutual recognition or via the decentralised procedure when there is disagreement between Member States on a variation (type II), on the grounds of a potential serious risk to public health.
- Authorisation model
- Nationally authorised product(s)
- Decision making model
- CHMP-EC
Key dates and outcomes
- Procedure start date
- 22/02/2024
- CHMP opinion date
- 27/06/2024
- EC decision date
- 29/08/2024